Literature DB >> 17354235

Six-month natural history of oral versus cervical human papillomavirus infection.

Gypsyamber D'Souza1, Carole Fakhry, Elizabeth A Sugar, Eric C Seaberg, Kathleen Weber, Howard L Minkoff, Kathryn Anastos, Joel M Palefsky, Maura L Gillison.   

Abstract

Human papillomavirus (HPV) infection is etiologically associated with a subset of oral cancers, and yet, the natural history of oral HPV infection remains unexplored. The feasibility of studying oral HPV natural history was evaluated by collecting oral rinse samples on 2 occasions at a 6-month interval from 136 HIV-positive and 63 HIV-negative participants. Cervical vaginal lavage samples were concurrently collected for comparison. HPV genomic DNA was detected in oral and cervical samples by consensus primer PCR and type-specified for 37 HPV types. The six-month cumulative prevalence of oral HPV infection was significantly less than for cervical infection (p < 0.0001). HIV-positive women were more likely than HIV-negative women to have an oral (33 vs. 15%, p = 0.016) or cervical (78 vs. 51%, p < 0.001) infection detected. Oral HPV infections detected at baseline were as likely as cervical infections to persist to 6 months among HIV-negative (60% vs. 51%, p = 0.70) and HIV-positive (55% vs. 63%, p = 0.27) women. Factors that independently elevated odds for oral HPV persistence differed from cervical infection and included current smoking (OR = 8, 95% CI = 1.3-53), age above 44 years (OR = 20, 95% CI = 4.1-83), CD4 < 500 (OR = 6, 95% CI = 1.1-26), use of HAART therapy (OR = 12, 95% CI = 1.0-156), and time on HAART therapy (trend p = 0.04). The rate of oral HPV infections newly detected at follow-up was significantly lower than cervical infection among HIV-positive (p < 0.001) and HIV-negative women (p < 0.001). Our study not only demonstrates that it is feasible to study the natural history of oral HPV infection with oral rinse sampling, but also indicates that oral and cervical HPV natural history may differ.

Entities:  

Mesh:

Year:  2007        PMID: 17354235     DOI: 10.1002/ijc.22667

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  74 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Sexual transmission of oral human papillomavirus infection among men.

Authors:  Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-12       Impact factor: 4.254

Review 3.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

Review 4.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

5.  Smoking increases oral HPV persistence among men: 7-year follow-up study.

Authors:  K Kero; J Rautava; K Syrjänen; J Willberg; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

6.  Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample.

Authors:  Ellen M Daley; Stephanie L Marhefka; Eric R Buhi; Cheryl A Vamos; Natalie D Hernandez; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

Review 7.  Discussing the diagnosis of HPV-OSCC: common questions and answers.

Authors:  Carole Fakhry; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2013-07-19       Impact factor: 5.337

8.  Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

Authors:  Gypsyamber Dʼsouza; Thomas E Carey; William N William; Minh Ly Nguyen; Eric C Ko; James Riddell; Sara I Pai; Vishal Gupta; Heather M Walline; J Jack Lee; Gregory T Wolf; Dong M Shin; Jennifer R Grandis; Robert L Ferris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

Review 9.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 10.  Epidemiology of HPV-associated oropharyngeal cancer.

Authors:  Kristen B Pytynia; Kristina R Dahlstrom; Erich M Sturgis
Journal:  Oral Oncol       Date:  2014-01-22       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.